Author:
Edition: 2004
Publisher: Humana Press
Binding: Hardcover
ISBN: 1588292282
Anticancer Drug Development Guide (Cancer Drug Discovery and Development)
This thoroughly updated and expanded second edition of Beverly Teicher's widely used classic survey provides a step-by-step guide to anticancer drug development from initial design through FDA approval. Medical books Anticancer Drug Development Guide . The authors have included new material on the use of high throughput screening in industry, on specialized in vitro/in vivo procedures employed by the National Cancer Institute (NCI) in preclinical drug evaluations, and on nonclinical testing to support both human clinical trials, as well as trials of biologic oncology products Medical books Anticancer Drug Development Guide By Beverly A. Teicher. TheNile.com.au About FAQ Payment Delivery Contact Us 1800-987-323 Anticancer Drug Development Guide by Beverly A. Teicher , Paul A. Andrews Format Hardcover Condition Brand New This thoroughly updated and expanded second edition of Beverly Teicher #039;s widely used classic survey provides a step-by-step guide to anticancer drug development from initial design through FDA approval. The authors have included new material on the use of high throughput screening in industry, on specialized in vitr
Download link for Anticancer Drug Development Guide (Cancer Drug Discovery and Development)
TheNile.com.au About FAQ Payment Delivery Contact Us 1800-987-323 Anticancer Drug Development Guide by Beverly A. Teicher , Paul A. Andrews Format Hardcover Condition Brand New This thoroughly updated and expanded second edition of Beverly Teicher #039;s widely used classic survey provides a step-by-step guide to anticancer drug development from initial design through FDA approval. The authors have included new material on the use of high throughput screening in industry, on specialized in vitr
Electronics Cameras Computers Software Housewares Sports DVDs Music Books Games Toys in titles descriptions Company Info |Checkout Info |Shipping Info |Return Policy |FAQ's Add us as a favorite seller By continuing with your purchase using the eBay Buy It Now button, you agree to the Buy Terms of Use at http://stores.ebay.com/Buys-Internet-Superstore/Terms.html . Anticancer Drug Development Guide - Teicher, Beverly A. (EDT)/ Andrews, Paul A. (EDT)THIS IS A BRAND NEW UNOPENED ITEM. Description T
This thoroughly updated and expanded second edition of Beverly Teicher's widely used classic survey provides a step-by-step guide to anticancer drug development from initial design through FDA approval. The authors have included new material on the use of high throughput screening in industry, on specialized in vitro/in vivo procedures employed by the National Cancer Institute (NCI) in preclinical drug evaluations, and on nonclinical testing to support both human clinical trials, as well as trials of biologic oncology products. The chapters on phase I, II, and III clinical trials and on novel
payment | shipping rates | returns Anticancer Drug Development Guide (Cancer Drug Discovery and Development) Product Category :Books ISBN :1588292282 Title :Anticancer Drug Development Guide (Cancer Drug Discovery and Development)EAN :9781588292285 Binding :Hardcover Publisher :Humana Press Publication Date :2004-02-01 Pages :430 Signed :False First Edition :False Dust Jacket :False List Price (MSRP) :179.00 Height :1.2600 inches Width :7.3400 inches Length :10.1000 inches Weight :2.5300 pounds
Medical Book Anticancer Drug Development Guide
The authors have included new material on the use of high throughput screening in industry, on specialized in vitro/in vivo procedures employed by the National Cancer Institute (NCI) in preclinical drug evaluations, and on nonclinical testing to support both human clinical trials, as well as trials of biologic oncology products. The chapters on phase I, II, and III clinical trials and on novel phase II clinical trial designs for targeted therapies have been significantly updated, along with those on cancer drug development in Europe, working with the NCI, and the FDA's role in cancer drug development and setting requirements for approval.
